Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations

Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Gross, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Woelwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen

Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations

Author:

Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Gross, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Woelwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen

Tübinger Autor(en):

Groß, Thorben

Published in:

European Journal of Cancer (2024), Bd. 207, Article 114158

Verlagsangabe:

London : Elsevier Sci Ltd

Language:

English

Full text:

http://dx.doi.org/10.1016/j.ejca.2024.114158

ISSN:

0959-8049